REG3A | Regenerating islet-derived 3 alpha | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
BTNL3 | Butyrophilin-like 3 | Predicted membrane proteins
| | | | | Group enriched |
LIPF | Lipase, gastric | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CEACAM18 | Carcinoembryonic antigen-related cell adhesion molecule 18 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CHP2 | Calcineurin-like EF-hand protein 2 | Cancer-related genes
| | | | | Group enriched |
NKX6-2 | NK6 homeobox 2 | Transcription factors
| | | | | Group enriched |
SLC52A1 | Solute carrier family 52 (riboflavin transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ALPI | Alkaline phosphatase, intestinal | Enzymes Predicted secreted proteins
| | | | | Group enriched |
C6orf58 | Chromosome 6 open reading frame 58 | Predicted secreted proteins
| | | | | Group enriched |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
TFF2 | Trefoil factor 2 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
MALRD1 | MAM and LDL receptor class A domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
NOX1 | NADPH oxidase 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A19 | Solute carrier family 6 (neutral amino acid transporter), member 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
KRTAP13-2 | Keratin associated protein 13-2 | Plasma proteins
| | | | | Group enriched |
MS4A12 | Membrane-spanning 4-domains, subfamily A, member 12 | Predicted membrane proteins
| | | | | Group enriched |
TFF1 | Trefoil factor 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ASAH2C | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C | Enzymes
| | | | | Group enriched |
MTTP | Microsomal triglyceride transfer protein | Disease related genes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
NKX6-3 | NK6 homeobox 3 | Transcription factors
| | | | | Group enriched |
SLC39A5 | Solute carrier family 39 (zinc transporter), member 5 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
TBX10 | T-box 10 | Predicted secreted proteins Transcription factors
| | | | | Group enriched |
KCNE2 | Potassium voltage-gated channel, Isk-related family, member 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
SLC5A12 | Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC9A4 | Solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound | Enzymes Predicted secreted proteins
| | | | | Group enriched |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
LRRC26 | Leucine rich repeat containing 26 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
MOGAT2 | Monoacylglycerol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
TUBAL3 | Tubulin, alpha-like 3 | | | | | | Group enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
CASP16 | Caspase 16, apoptosis-related cysteine peptidase (putative) | Enzymes
| | | | | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CFC1 | Cripto, FRL-1, cryptic family 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
MUC12 | Mucin 12, cell surface associated | Predicted membrane proteins
| | | | | Group enriched |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes
| | | | | Group enriched |
NLRP6 | NLR family, pyrin domain containing 6 | Plasma proteins
| | | | | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CHIA | Chitinase, acidic | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CLDN15 | Claudin 15 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CYP2D6 | Cytochrome P450, family 2, subfamily D, polypeptide 6 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
DEFB131 | Defensin, beta 131 | Predicted secreted proteins
| | | | | Tissue enriched |
DPCR1 | Diffuse panbronchiolitis critical region 1 | Predicted membrane proteins
| | | | | Tissue enriched |
GAL3ST2 | Galactose-3-O-sulfotransferase 2 | Predicted secreted proteins
| | | | | Group enriched |
LINC00955 | Long intergenic non-protein coding RNA 955 | Predicted membrane proteins
| | | | | Group enriched |
MYRFL | Myelin regulatory factor-like | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |